ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

AstraZeneca Needs To Replenish Drug Pipeline - Chairman

By Marta Falconi ZURICH--AstraZeneca PLC (AZN) aims to replenish its thin pipeline of new drugs through external collaborations and by buying drugs in late stages of development from other drugmakers, Chairman Leif Johansson said in an interview Tuesday. His comments come after the company announced it appointed former Roche head of pharma, Pascal Soriot, as chief executive, to succeed David Brennan, who earlier this year retired abruptly amid shareholder dissatisfaction with the company's performance. "There's a number of medicines going off patent," Mr. Johansson said. "We need to replenish them." The U.K.'s No. 2 drug maker by sales, after GlaxoSmithKline PLC (GSK), has suffered a number of expensive drug-development failures, and shown a poor track record in bringing new medicines to market, analysts say. Some of AstraZeneca's biggest drugs are facing, or will soon face, competition from low-cost generics. Mr. Johansson also said that while the pharmaceutical sector is facing challenges, there are also opportunities, such as the possibility of buying buy late-stage drugs, emerging markets and advances in science, including genome technology, which he touted as a way to learn how the human body works and possibly help find new drugs. Write to Marta Falconi at marta.falconi@dowjones.com Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Glaxosmithkline (GSK)
DateTimeHeadline
07/02/201503:00:00ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement...
07/01/201512:30:03Report of Foreign Issuer (6-k)
07/01/201510:17:12Report of Foreign Issuer (6-k)
07/01/201506:45:47Report of Foreign Issuer (6-k)
06/29/201509:43:033 Reasons I Have Little Confidence in GlaxoSmithKline's Dividend
06/24/201513:32:00U.S. CDC committee recommends physicians make individual decisions...
06/24/201506:17:56Report of Foreign Issuer (6-k)
06/22/201518:35:21ADRs End Higher; National Bank of Greece Rises
06/22/201508:20:10Pfizer to Acquire Two Meningitis Vaccines
06/22/201507:48:45Report of Foreign Issuer (6-k)
06/22/201507:47:44GlaxoSmithKline Sells Meningitis Vaccines to Pfizer For EUR115...
06/21/201514:03:02The Best Return on Equity in Healthcare
06/21/201507:09:033 Healthcare Dividends That Could Be in Big Trouble
06/18/201514:49:09British Investigator Says Chinese Officials Tried to Force Confession...
06/18/201504:32:12Correction to British Investigator Story
06/18/201504:10:36British Investigator Says Chinese Officials Tried to Force Confession...
06/18/201503:53:03British Investigator Says Chinese Officials Tried to Force Confession...
06/18/201503:07:32British Investigator Says Chinese Officials Tried to Force Confession
06/14/201510:03:02Wow! This Biotech IPO Doubled on Day One
06/11/201516:44:16Report of Foreign Issuer (6-k)

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad